NervGen Pharma Corp

(OTC:NGENF)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

NervGen Pharma Corp. is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The Company is developing drugs for the treatment of spinal cord injury, multiple sclerosis and Alzheimer's disease. NervGen's platform technology targets protein tyrosine phosphatase sigma ("PTPsigma"), a neural receptor that impedes nerve repair. Inhibition of the PTPsigma receptor has been shown to promote regeneration and remyelination of damaged nerves, as well as improvement of nerve function in animal models for various medical conditions.

Contact Information

Website: www.nervgen.com
Main Phone: +1 604 488-5421
Address: 595 Burrard Street
Address 2: Suite 1703, Three Bentall Centre
State: BC
City / Town: Vancouver
Country: CA
Postal Code: V7X 1J1

Issuer Information

Exchange: OTCQX
CEO: Paul Brennan
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A